Table 2.
Adverse events in diabetics who received intracameral ICMA or a topical regimen for cataract surgery (Safety set)
| ICMA Group | Topical Group |
|---|---|
| Complications (number of patients) | Complications (number of patients) |
| Mild conjunctival hyperaemia (1) | Mild conjunctivitis (1) |
| Mild punctate keratitis (1) | Moderate punctate keratitis (2) |
| Moderate dry eye (1) | |
| Moderate eyelid ptosis (1) | |
| Moderate posterior capsule rupture (1)a | |
| Severe transient ischaemic attack (1) | Mild type 2 diabetes mellitus (1) |
ICMA Group = patients who received an intracameral injection of a standardized combination of 1% lidocaine, 0.02% tropicamide, and 0.31% phenylephrine immediately after the 1st corneal incision
Topical Group = patients who received a topical regimen of 1 drop each of 10% phenylephrine and 0.5% tropicamide. aModerate posterior capsule rupture was a limited rupture that did not require anterior vitrectomy